title: Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales
source: Yahoo
date: 2025-10-06
url: https://finnhub.io/api/news?id=573d8914e3ef9fad50a1ea6b198e72cb967f01059ea7aa20de2221e010924213
LONDON and RALEIGH, N.C., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive agreement on July 8, 2025 relating to its proposed acquisition by MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA), known as Merck in the U.S. and Canada, through a wholly owned subsidiary or a nominee, today announced that the High Court of Justice of England and Wales has approved the
